Publisher
Springer International Publishing
Reference44 articles.
1. Al Hamarneh YN, Charrois T, Lewanczuk R, Tsuyuki RT. Pharmacist intervention for glycaemic control in the community (the RxING study). BMJ Open. 2013;3(9). https://doi.org/10.1136/bmjopen-2013-003154.
2. Al Hamarneh YN, Johnston K, Marra CA, Tsuyuki RT. Pharmacist prescribing and care improves cardiovascular risk, but is it cost-effective? A cost-effectiveness analysis of the RxEACH study. Can Pharm J (Ott). 2019;152(4):257–66. Published 2019 Jun 10. https://doi.org/10.1177/1715163519851822.
3. Al Harmarneh YN, Lamb S, Donald M, et al. Pharmacist prescribing and care improves cardiovascular risk, but what do patients think? A substudy of the RxEACH study. Can Pharm J. 2018;151(4):223–7. https://doi.org/10.1177/1715163518779092.
4. American Pharmacists Association. Medication Therapy Management in Pharmacy Practice: Core Elements of an MTM Service Model. Version 2.0. 2008. Available online from: https://s3.amazonaws.com/filehost.pharmacist.com/CDN/PDFS/Practice/core_elements_of_an_mtm_practice.pdf?AWSAccessKeyId=AKIAYICBVAN2V7IWVG4T&Expires=1623105746&Signature=WbQKNgEf0FKQlFyOaQXjSg22qes%3D. Accessed 7 June 2021.
5. Asthma – United States: 1980-90. MMWR Morb Mortal Wkly Rep. 1992;41:733–5.